AbCellera Biologics Inc

8QQ

Company Profile

  • Business description

    AbCellera Biologics Inc is an antibody discovery and development engine that’s specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company’s experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

  • Contact

    150 W 4th Avenue
    VancouverBCV5Y 1G6
    CAN

    T: +1 604 559-9005

    E: [email protected]

    https://www.abcellera.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    596

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,149.808.90-0.11%
CAC 408,042.9551.25-0.63%
DAX 4022,891.68107.47-0.47%
Dow JONES (US)41,985.3532.030.08%
FTSE 1008,646.7955.20-0.63%
HKSE23,640.8548.87-0.21%
NASDAQ17,784.0592.420.52%
Nikkei 22537,676.970.09-0.00%
NZX 50 Index12,126.6513.110.11%
S&P 5005,667.564.670.08%
S&P/ASX 2007,926.504.70-0.06%
SSE Composite Index3,364.900.070.00%

Market Movers